Phase I Study of SHR-2022 Injection in the Treatment of Patients With Advanced Malignant Tumors
Phase I Study of SHR-2022 Injection in the Treatment of Patients With Advanced Malignant Tumors
Not yet recruiting · NCT06131216 · Registry updated 2023-11-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I Study of SHR-2022 Injection in the Treatment of Patients With Advanced Malignant Tumors | Advanced Malignant Cancer | Not yet recruiting | Phase 1 | 2023-11-14 | NCT06131216 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 74 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||